Newsletter | September 9, 2025

09.09.25 -- CDMOs Should Stop Stringing Biotechs Along

SPONSOR

Count on Labcorp's biopharmaceutical CMC services' depth of scientific leadership, excellent regulatory history and global laboratory network to help drive progress in your drug development journey. Highly skilled in characterization, formulation, analytical development and QC testing, our experts will partner with you to objectively advance your programs across a broad range of modalities. With more than three decades of CMC analytical experience, we can help you advance your most challenging projects when it matters most.

FOCUS ON OUTSOURCING

CDMOs Should Stop Stringing Biotechs Along

Biotechs, first working closely with a CDMO’s sales manager, experience subsequent and sudden rejections of their projects. Did some of you just wince? If so, that might be because we are again hearing of a problem with sudden rejections after protracted discussions and even site visits.

Reaching First-In-Human Trials Faster: Connect With The Right Partner

Assessing outsourcing partners’ credentials in people, technology, supply chains, and integration will make all the difference as sponsors aim to streamline processes on the path to commercialization.

Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

Unlocking Agility And Efficiency In Biomanufacturing

Discover a standardized yet flexible modular biomanufacturing system designed to accelerate timelines, improve scalability, and enhance quality while reducing costs and environmental impact.

Successfully Producing Insoluble Proteins Using Inclusion Bodies

Review the pros and cons of soluble and insoluble processes, experiences with isolating, solubilizing, and properly re-folding, and strategies and innovation to improve insoluble processes.

Navigating The Analytical Complexity Of Oligonucleotide Therapeutics

From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.

Leveraging Technology For Rapid Clinical Material Delivery

Discover how one family's collaboration with a specialized CDMO enabled the rapid development of a life-saving gene therapy for their daughter diagnosed with an ultra-rare disease.

Antibody-Drug Conjugates: Next Generation Of Targeted Cancer Treatments

Manufacturing complex and highly potent ADC treatments presents unique challenges. Get an insider look at how these treatments make it from development to commercialization.

SPONSOR

Join Bioprocess Online Live on September 9 at 11am ET for a Q&A with CMC and MSAT experts about how companies can align their teams to overcome internal barriers and unlock the promise of PATs. Registration is free for this digital event.

OUTSOURCING SOLUTIONS

Mammalian Cell Culture Expertise - Boehringer Ingelheim Biopharmaceuticals GmbH

A Complete CRISPR Workflow From The Lab To The Clinic - Danaher Life Sciences

Simtra Capabilities Overview - Simtra BioPharma Solutions

Organoid-Based Drug Screening Services - Samsung Biologics

Connect With Bioprocess Online: